Stock of the week: “Siemens Healthineers AG”
Siemens Healthineers AG operates as a holding company. The company intends to operate the digital services business. It operates through the following business segments: Imaging, Diagnostics, and Advanced Therapies.
The Imaging segment provides state-of-the-art diagnostic imaging products and a diverse range of advanced imaging, ultrasound systems, and solutions. The Diagnostics segment offers a wide selection of test applications for laboratory diagnostics, point-of-care diagnostics and molecular diagnostics.
The Advanced Therapies segment is dedicated to providing healthcare providers with high-end advanced therapy products, services and solutions.
Recently, Bernstein Research gave Siemens Healthineers an "outperform" rating with a price target of €58. According to some analysts, Siemens Healthineers is a high-quality equipment supplier that benefits from several key industry trends globally. A strong order book, price increases and impressive cost management should lead to strong earnings growth.
The group’s financial social media sentiment tends to be “positive” in both absolute and relative terms, on its own and when compared to the social media sentiment of the sector and stock index.
Analyst consensus is to "buy" the stock - out of the 17 bank analysts covering the company, 14 recommend buying the stock and 3 suggest holding it. The median upside potential of the stock price expected by these analysts over the next 6-12 months is currently 17.46% (reference close of business 07/03/2023).
Attention buzz is currently “high”.
Sources:
https://umushroom.com/en/equity/siemens-health-rg
